Trial site
New York University Langone Health
- 17running trials
- 11closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease4 trials
- Lung cancer4 trials
- Prostate cancer3 trials
- Childhood cancers2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Triple-negative breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Endometrial cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- and 14 more
- Phase
- Phase 1/210 trials
- Phase 26 trials
- Phase 35 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting9 trials
- Completed8 trials
- Recruiting7 trials
- Terminated3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Tango Therapeutics, Inc.3 trials
- Cullinan Therapeutics Inc.2 trials
- Day One Biopharmaceuticals, Inc.2 trials
- Regeneron Pharmaceuticals2 trials
- United Therapeutics2 trials
- and 17 more
Running trials
Recruiting
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
Not yet recruiting
A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients
Recruiting
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Active, not recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Recruiting
Active, not recruiting
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Active, not recruiting
Active, not recruiting
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease3 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Endometrial cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Neurofibromatosis type 11 recruiting
- Ovarian cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)
Terminated
Completed
Completed
Terminated
Completed
A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.
Completed
Completed
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study
Completed
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026